{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:17:19Z","timestamp":1783444639113,"version":"3.54.6"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11882-011-0190-y","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T03:03:46Z","timestamp":1301454226000},"page":"197-204","source":"Crossref","is-referenced-by-count":49,"title":["Guillain-Barr\u00e9 Syndrome: Modern Theories of Etiology"],"prefix":"10.1007","volume":"11","author":[{"given":"Todd A.","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"McCombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"190_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ni0107-8","volume":"8","author":"R Zinkernagel","year":"2007","unstructured":"Zinkernagel R. On observing and analyzing disease versus signals. Nat Immunol. 2007;8:8\u201310.","journal-title":"Nat Immunol"},{"key":"190_CR2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","volume":"70","author":"A Alshekhlee","year":"2008","unstructured":"Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608\u201313.","journal-title":"Neurology"},{"key":"190_CR3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn van","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2008;7:939\u201350.","journal-title":"Lancet Neurol"},{"key":"190_CR4","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RAC Hughes","year":"2005","unstructured":"Hughes RAC, Cornblath DR. Guillain-Barre syndrome. Lancet. 2005;366:1653\u201366.","journal-title":"Lancet"},{"key":"190_CR5","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","volume":"74","author":"L Ruts","year":"2010","unstructured":"Ruts L, Drenthen J, Jacobs BC, Van Doorn PA. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010;74:1680\u20136.","journal-title":"Neurology"},{"key":"190_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol. 1979;110:105\u201323.","journal-title":"Am J Epidemiol"},{"key":"190_CR7","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","volume":"339","author":"T Lasky","year":"1998","unstructured":"Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines. N Engl J Med. 1998;339:1797\u2013802.","journal-title":"N Engl J Med"},{"key":"190_CR8","unstructured":"2009 H1N1 flu. Available at: http:\/\/www.cdc.gov\/h1n1flu ."},{"key":"190_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","volume":"32","author":"P Haber","year":"2009","unstructured":"Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barre syndrome. Drug Saf. 2009;32:309\u201323.","journal-title":"Drug Saf"},{"key":"190_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","volume":"48","author":"AK Asbury","year":"1969","unstructured":"Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Medicine. 1969;48:173\u2013215.","journal-title":"Medicine"},{"key":"190_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","volume":"30","author":"BC Kieseier","year":"2004","unstructured":"Kieseier BC, Kiefer R, Gold R, et al. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve. 2004;30:131\u201356.","journal-title":"Muscle Nerve"},{"key":"190_CR12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","volume":"76","author":"PA Csurhes","year":"2005","unstructured":"Csurhes PA, Sullivan AA, Green K, et al. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2005;76:1431\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"190_CR13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jocn.2009.07.096","volume":"17","author":"PA McCombe","year":"2010","unstructured":"McCombe PA, Csurhes PA. T cells from patients with Guillain-Barre syndrome produce interferon-gamma in response to stimulation with the ganglioside GM1. J Clin Neurosci. 2010;17:537\u20138.","journal-title":"J Clin Neurosci"},{"key":"190_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","volume":"192","author":"L-J Chi","year":"2007","unstructured":"Chi L-J, Wang H-B, Zhang Y, Wang W-Z. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barre syndrome. J Neuroimmunol. 2007;192:206\u201314.","journal-title":"J Neuroimmunol"},{"key":"190_CR15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","volume":"15","author":"J Harness","year":"2008","unstructured":"Harness J, McCombe PA. Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain-Barr\u00e9 syndrome patients compared to controls. J Clin Neurosci. 2008;15:1031\u20135.","journal-title":"J Clin Neurosci"},{"key":"190_CR16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol. 1996;39:625\u201335.","journal-title":"Ann Neurol"},{"key":"190_CR17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp.2006.106617","volume":"78","author":"HR Inglis","year":"2007","unstructured":"Inglis HR, Csurhes PA, McCombe PA. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. J Neurol Neurosurg Psychiatry. 2007;78:419\u201322.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"190_CR18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","volume":"109","author":"TE Feasby","year":"1986","unstructured":"Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barre polyneuropathy. Brain. 1986;109:1115\u201326.","journal-title":"Brain"},{"key":"190_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","volume":"33","author":"GM McKhann","year":"1993","unstructured":"McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993;33:333\u201342.","journal-title":"Ann Neurol"},{"key":"190_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","volume":"39","author":"JW Griffin","year":"1996","unstructured":"Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann Neurol. 1996;39:17\u201328.","journal-title":"Ann Neurol"},{"key":"190_CR21","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1212\/WNL.53.9.2122","volume":"53","author":"CW Ang","year":"1999","unstructured":"Ang CW, Yuki N, Jacobs BC, et al. Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-GalNAc-GD1a antibodies. Neurology. 1999;53:2122\u20137.","journal-title":"Neurology"},{"key":"190_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","volume":"45","author":"TW Ho","year":"1999","unstructured":"Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome. Ann Neurol. 1999;45:168\u201373.","journal-title":"Ann Neurol"},{"key":"190_CR23","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N Yuki","year":"2001","unstructured":"Yuki N, Yamada M, Koga M, et al. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol. 2001;49:712\u201320.","journal-title":"Ann Neurol"},{"key":"190_CR24","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/brain\/awn074","volume":"131","author":"PHH Lopez","year":"2008","unstructured":"Lopez PHH, Zhang G, Bianchet MA, et al. Structural requirements of anti-GD1a antibodies determine their target specificity. Brain. 2008;131:1926\u201339.","journal-title":"Brain"},{"key":"190_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2010.02.001","volume":"223","author":"K Kaida","year":"2010","unstructured":"Kaida K, Kusunoki S. Antibodies to gangliosides and ganglioside complexes in Guillain-Barre syndrome and Fisher syndrome: Mini-review. J Neuroimmunol. 2010;223:5\u201312.","journal-title":"J Neuroimmunol"},{"key":"190_CR26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/WCO.0b013e32830b84b7","volume":"21","author":"S Rinaldi","year":"2008","unstructured":"Rinaldi S, Willison HJ. Ganglioside antibodies and neuropathies. Curr Opin Neurol. 2008;21:540\u20136.","journal-title":"Curr Opin Neurol"},{"key":"190_CR27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996;40:635\u201344.","journal-title":"Ann Neurol"},{"key":"190_CR28","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","volume":"131","author":"SK Halstead","year":"2008","unstructured":"\u2022 Halstead SK, Zitman FMP, Humphreys PD, et al: Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 2008, 131:1197\u20131208. This study demonstrated a realistic therapy for possible trials in human GBS.","journal-title":"Brain"},{"key":"190_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-510X(99)00180-X","volume":"168","author":"N Yuki","year":"1999","unstructured":"Yuki N, Kuwabara S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile. J Neurol Sci. 1999;168:121\u20136.","journal-title":"J Neurol Sci"},{"key":"190_CR30","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/jnnp.2010.208538","volume":"81","author":"A Uncini","year":"2010","unstructured":"Uncini A, Manzoli C, Notturno F, Capasso M. Pitfalls in electrodiagnosis of Guillain-Barr\u00e9 syndrome subtypes. J Neurol Neurosurg Psychiatry. 2010;81:1157\u201363.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"190_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01175417","volume":"6","author":"RE Madrid","year":"1977","unstructured":"Madrid RE, Wi\u015bniewski HM. Axonal degeneration in demyelinating disorders. J Neurocytol. 1977;6:103\u201317.","journal-title":"J Neurocytol"},{"key":"190_CR32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2353\/ajpath.2009.090340","volume":"175","author":"B Sobottka","year":"2009","unstructured":"Sobottka B, Harrer MD, Ziegler U, et al. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am J Pathol. 2009;175:1160\u20136.","journal-title":"Am J Pathol"},{"key":"190_CR33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","volume":"31","author":"A Chiba","year":"1992","unstructured":"Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31:677\u20139.","journal-title":"Ann Neurol"},{"key":"190_CR34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/282313","volume":"98","author":"RT Damian","year":"1964","unstructured":"Damian RT. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am Nat. 1964;98:129\u201349.","journal-title":"Am Nat"},{"key":"190_CR35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1529-8027.2007.00153.x","volume":"12","author":"N Yuki","year":"2007","unstructured":"Yuki N, Kuwabara S. Axonal Guillain-Barre syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst. 2007;12:238\u201349.","journal-title":"J Peripher Nerv Syst"},{"key":"190_CR36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/89831","volume":"7","author":"A Belkum van","year":"2001","unstructured":"van Belkum A, van den Braak N, Godschalk P, et al. A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat Med. 2001;7:752\u20133.","journal-title":"Nat Med"},{"key":"190_CR37","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1212\/01.wnl.0000176914.70893.14","volume":"65","author":"M Koga","year":"2005","unstructured":"Koga M, Takahashi M, Masuda M, et al. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome. Neurology. 2005;65:1376\u201381.","journal-title":"Neurology"},{"key":"190_CR38","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/brain\/awh231","volume":"127","author":"SK Halstead","year":"2004","unstructured":"Halstead SK, O\u2019Hanlon GM, Humphreys PD, et al. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain. 2004;127:2109\u201323.","journal-title":"Brain"},{"key":"190_CR39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410380214","volume":"38","author":"I Illa","year":"1995","unstructured":"Illa I, Ortiz N, Gallard E, et al. Acute axonal Guillain-Barre syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol. 1995;38:218\u201324.","journal-title":"Ann Neurol"},{"key":"190_CR40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1074-7613(00)00025-X","volume":"13","author":"A Shamshiev","year":"2000","unstructured":"Shamshiev A, Donda A, Prigozy TI, et al. The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity. 2000;13:255\u201364.","journal-title":"Immunity"},{"key":"190_CR41","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U","volume":"29","author":"A Shamshiev","year":"1999","unstructured":"Shamshiev A, Donda A, Carena I, et al. Self glycolipids as T-cell autoantigens. Eur J Immunol. 1999;29:1667\u201375.","journal-title":"Eur J Immunol"},{"key":"190_CR42","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI200423594","volume":"114","author":"DI Godfrey","year":"2004","unstructured":"Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Investig. 2004;114:1379\u201388.","journal-title":"J Clin Investig"},{"key":"190_CR43","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/brain\/118.4.857","volume":"118","author":"JM Spies","year":"1995","unstructured":"Spies JM, Westland KW, Bonner JG, Pollard JD. Intraneural activated T cells cause focal breakdown of the blood\u2013nerve barrier. Brain. 1995;118:857\u201368.","journal-title":"Brain"},{"key":"190_CR44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.410370409","volume":"37","author":"JD Pollard","year":"1995","unstructured":"Pollard JD, Westland KW, Harvey GK, et al. Activated T cells of nonneural specificity open the blood\u2013nerve barrier to circulating antibody. Ann Neurol. 1995;37:467\u201375.","journal-title":"Ann Neurol"},{"key":"190_CR45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"TW Ho","year":"1995","unstructured":"Ho TW, Mishu B, Li CY, et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995;118:597\u2013605.","journal-title":"Brain"},{"key":"190_CR46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.2008.156463","volume":"80","author":"K Kuitwaard","year":"2009","unstructured":"\u2022 Kuitwaard K, van Koningsveld R, Ruts L, et al: Recurrent Guillain Barre syndrome. Journal of Neurology, Neurosurgery & Psychiatry 2009, 80:56\u201359. This article confirmed the low rate of recurrent GBS and demonstrated that the few patients who do have recurrences have other features of autoimmunity, and that the standard on-off case does not.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"190_CR47","doi-asserted-by":"crossref","unstructured":"\u2022 Steiner I, Rosenberg G, Wirguin I: Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barre syndrome? Clin Exp Immunol 2010. This article presents an interesting related hypothesis that suggests more of a role for transient immunosuppression as an initiating feature but also deals well with the reasons why GBS is not a typical autoimmune disease.","DOI":"10.1111\/j.1365-2249.2010.04223.x"},{"key":"190_CR48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ni0107-11","volume":"8","author":"P Matzinger","year":"2007","unstructured":"Matzinger P. Friendly and dangerous signals: is the tissue in control? Nat Immunol. 2007;8:11\u20133.","journal-title":"Nat Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-011-0190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-011-0190-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-011-0190-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T10:28:14Z","timestamp":1560076094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-011-0190-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1007\/s11882-011-0190-y","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]}}}